Clinical Trials Directory

Trials / Completed

CompletedNCT02884323

A Study in Patients With Venous Leg Ulcers and Measuring the Effects of Using Geko™ Device

A Single Centre Open Label Pilot Study Measuring Lower Limb Physiology in Patients With Venous Leg Ulcers Using the Geko™ T-2 or gekoTM Plus [R-2] Neuromuscular Electro Stimulation Device

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Firstkind Ltd · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

This is a single centre open label study measuring lower limb physiology in patients with venous leg ulcers at the University Hospital of South Manchester. Ambulatory venous pressure, venous transit times, wound bed tissue oxygenation and changes in microcirculation will be measured at baseline after the gekoTM device is activated. Ambulatory venous pressure and venous transit times will be performed whilst the participant is standing, sitting and supine

Conditions

Interventions

TypeNameDescription
DEVICEgeko™ deviceThe geko™ (T-2 and R-2) devices are small disposable, internally powered, neuromuscular stimulators that are applied externally to the leg.

Timeline

Start date
2016-08-01
Primary completion
2018-07-02
Completion
2018-07-02
First posted
2016-08-31
Last updated
2022-05-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02884323. Inclusion in this directory is not an endorsement.